Skip to Main Content Menu Search Site

DoriVac: DNA Origami-Based Vaccines for Combination Immunotherapy

Personalized immunotherapy platform harnessing DNA nanotechnology to co-deliver drug combinations with nanoscale precision

Want to learn more about DoriVac?

We are currently looking for funding opportunities, and collaborative partners in academia and industry.


Molecular Robotics

Technology Development Team
Key Features
  • DNA nanoparticles enable precise placement of cargoes including adjuvants and off-the-shelf or patient-specific tumor antigens
  • Demonstrated preclinical efficacy in several different mouse tumors models such as melanoma, lymphoma, colon cancer, lung cancer, and neuroblastoma
  • Applicable to cancer, autoimmune diseases, and infectious diseases
Close menu